Archive for Декабрь 20th, 2008
UK Company Plans Trial of Diet Drug With Same Target as Acomplia (Rimonabant)
GW Pharmaceuticals Acomplia (rimonabant) , a U.K. company with an announced goal of being the global leader in prescription cannabinoid medicine, said on Jan. 30 it hopes to soon start a Phase I clinical trial of an experimental diet drug derived from cannabis.
The company said researchers had [...]
